Operating Income Summary of ChemoMetec A/S

ChemoMetec A/S's latest annual operating income in 2024 was 178.78 Million DKK , down -22.46% from previous year.
ChemoMetec A/S's latest quarterly operating income in 2024 FY was 176.76 Million DKK , down -23.33% from previous quarter.
ChemoMetec A/S reported an annual operating income of 230.56 Million DKK in 2023, up 13.66% from previous year.
ChemoMetec A/S reported an annual operating income of 202.85 Million DKK in 2022, up 74.84% from previous year.
ChemoMetec A/S reported a quarterly operating income of 176.76 Million DKK for 2024 FY, down -23.33% from previous quarter.
ChemoMetec A/S reported a quarterly operating income of 42.32 Million DKK for 2024 Q1, down -55.79% from previous quarter.

Annual Operating Income Chart of ChemoMetec A/S (2024 - 2004)

Historical Annual Operating Income of ChemoMetec A/S (2024 - 2004)

Year	Operating Income	Operating Income Growth
2024	178.78 Million DKK	-22.46%
2023	230.56 Million DKK	13.66%
2022	202.85 Million DKK	74.84%
2021	116.02 Million DKK	49.77%
2020	77.47 Million DKK	43.25%
2019	54.07 Million DKK	122.69%
2018	24.28 Million DKK	133.07%
2017	10.41 Million DKK	-34.46%
2016	15.89 Million DKK	172.77%
2015	5.82 Million DKK	358.18%
2014	1.27 Million DKK	-12.94%
2013	1.46 Million DKK	112.71%
2012	-11.49 Million DKK	-1586.93%
2011	773 Thousand DKK	161.35%
2010	-1.26 Million DKK	-161.17%
2009	2.06 Million DKK	-86.05%
2008	14.76 Million DKK	931.8%
2007	1.43 Million DKK	90.55%
2006	751 Thousand DKK	489.12%
2005	-193 Thousand DKK	97.73%
2004	-8.5 Million DKK	0.0%

Year	Operating Income	Operating Income Growth
2024 Q4	44.49 Million DKK	0.0%
2024 FY	176.76 Million DKK	-23.33%
2024 Q1	42.32 Million DKK	-55.79%
2024 Q2	42.32 Million DKK	0.0%
2024 Q3	44.49 Million DKK	5.14%
2023 FY	230.56 Million DKK	13.66%
2023 Q4	95.72 Million DKK	99.85%
2023 Q3	47.89 Million DKK	-63.91%
2023 Q2	132.7 Million DKK	96.95%
2023 Q1	67.38 Million DKK	-29.28%
2022 FY	202.85 Million DKK	74.84%
2022 Q1	53.12 Million DKK	-9.02%
2022 Q2	106.24 Million DKK	100.0%
2022 Q3	48.3 Million DKK	-54.54%
2022 Q4	95.28 Million DKK	97.27%
2021 FY	116.02 Million DKK	49.77%
2021 Q4	58.38 Million DKK	100.0%
2021 Q3	29.19 Million DKK	-49.35%
2021 Q2	57.63 Million DKK	100.0%
2021 Q1	28.81 Million DKK	-29.37%
2020 Q2	36.43 Million DKK	100.0%
2020 Q1	18.21 Million DKK	-31.74%
2020 Q4	40.8 Million DKK	81.18%
2020 Q3	22.51 Million DKK	-38.19%
2020 FY	77.47 Million DKK	43.25%
2019 Q4	26.68 Million DKK	104.82%
2019 Q2	14.01 Million DKK	0.0%
2019 Q1	14.01 Million DKK	100.86%
2019 FY	54.07 Million DKK	122.69%
2019 Q3	13.02 Million DKK	-7.0%
2018 Q4	6.97 Million DKK	0.0%
2018 Q2	5.16 Million DKK	0.0%
2018 FY	24.28 Million DKK	133.07%
2018 Q1	5.16 Million DKK	24.34%
2018 Q3	6.97 Million DKK	34.99%
2017 Q3	4.15 Million DKK	294.26%
2017 FY	10.41 Million DKK	-34.46%
2017 Q4	4.15 Million DKK	0.0%
2017 Q2	1.05 Million DKK	0.0%
2017 Q1	1.05 Million DKK	-63.6%
2016 FY	15.89 Million DKK	172.77%
2016 Q1	5.05 Million DKK	554.89%
2016 Q2	5.05 Million DKK	0.0%
2016 Q4	2.89 Million DKK	0.0%
2016 Q3	2.89 Million DKK	-42.68%
2015 Q4	771.5 Thousand DKK	0.0%
2015 FY	5.82 Million DKK	358.18%
2015 Q2	2.14 Million DKK	0.0%
2015 Q1	2.14 Million DKK	525.94%
2015 Q3	771.5 Thousand DKK	-63.99%
2014 Q1	1.32 Million DKK	3456.96%
2014 Q3	-503 Thousand DKK	-137.93%
2014 Q4	-503 Thousand DKK	0.0%
2014 FY	1.27 Million DKK	-12.94%
2014 Q2	1.32 Million DKK	0.0%
2013 Q2	770 Thousand DKK	0.0%
2013 Q4	-39.5 Thousand DKK	0.0%
2013 Q3	-39.5 Thousand DKK	-105.13%
2013 Q1	770 Thousand DKK	127.64%
2013 FY	1.46 Million DKK	112.71%
2012 Q3	-2.78 Million DKK	-4966.81%
2012 Q4	-2.78 Million DKK	0.0%
2012 FY	-11.49 Million DKK	-1586.93%
2012 Q2	57.25 Thousand DKK	0.0%
2012 Q1	57.25 Thousand DKK	0.0%
2011 Q1	-315 Thousand DKK	0.0%
2011 Q4	57.25 Thousand DKK	0.0%
2011 Q3	57.25 Thousand DKK	118.17%
2011 FY	773 Thousand DKK	161.35%
2011 Q2	-315 Thousand DKK	0.0%
2010 Q3	-315 Thousand DKK	-148.28%
2010 Q2	652.5 Thousand DKK	0.0%
2010 Q4	-315 Thousand DKK	0.0%
2010 Q1	652.5 Thousand DKK	0.0%
2010 FY	-1.26 Million DKK	-161.17%
2009 Q4	652.5 Thousand DKK	0.0%
2009 Q2	3.74 Million DKK	0.0%
2009 Q1	3.74 Million DKK	0.0%
2009 FY	2.06 Million DKK	-86.05%
2009 Q3	652.5 Thousand DKK	-82.59%
2008 FY	14.76 Million DKK	931.8%
2008 Q4	3.74 Million DKK	0.0%
2008 Q3	3.74 Million DKK	1218.29%
2008 Q1	284.25 Thousand DKK	0.0%
2008 Q2	284.25 Thousand DKK	0.0%
2007 Q4	284.25 Thousand DKK	0.0%
2007 Q3	284.25 Thousand DKK	51.0%
2007 Q2	188.25 Thousand DKK	0.0%
2007 FY	1.43 Million DKK	90.55%
2007 Q1	188.25 Thousand DKK	0.0%
2006 Q4	188.25 Thousand DKK	0.0%
2006 Q3	188.25 Thousand DKK	490.16%
2006 FY	751 Thousand DKK	489.12%
2006 Q1	-48.25 Thousand DKK	0.0%
2006 Q2	-48.25 Thousand DKK	0.0%
2005 FY	-193 Thousand DKK	97.73%
2005 Q3	-48.25 Thousand DKK	97.73%
2005 Q1	-2.12 Million DKK	0.0%
2005 Q2	-2.12 Million DKK	0.0%
2005 Q4	-48.25 Thousand DKK	0.0%
2004 Q4	-2.12 Million DKK	0.0%
2004 Q3	-2.12 Million DKK	0.0%
2004 FY	-8.5 Million DKK	0.0%

Peer Operating Income Comparison of ChemoMetec A/S

Name	Operating Income	Operating Income Difference
Ambu A/S	645 Million DKK	72.282%
Demant A/S	4.14 Billion DKK	95.69%
GN Store Nord A/S	869 Million DKK	79.427%
Scandinavian Medical Solutions A/S	16.62 Million DKK	-975.274%
ViroGates A/S	-12.56 Million DKK	1522.857%

Global Stocks Search

ChemoMetec A/S (CHEMM.CO)

Operating Income Summary of ChemoMetec A/S

Annual Operating Income Chart of ChemoMetec A/S (2024 - 2004)

Historical Annual Operating Income of ChemoMetec A/S (2024 - 2004)

Peer Operating Income Comparison of ChemoMetec A/S